These types of variants in BARD1 occur more frequently in familial/early onset CRC patients (5/1006; 0.5%) than in controls (2/1609; 0.12%) [28]; however, additional evidence is needed to elucidate the role of BARD1 in hereditary CRC. Here, BARD1 is linked to colorectal carcinoma.